Publications | Pharmacists & Patient Outcomes
Pharmacist & Outcomes – ALL
CONCLUSIONS: This study demonstrates the value of integrating pharmacists into HCV treatment teams to meet public health needs. [...]
CONCLUSION: While current pharmacist MTM payment modalities do not entirely compensate for pharmacist costs, pharmacists are successfully obtaining payment for their services. Future advocacy efforts need to focus on establishing consistent billing requirements and increasing payment for service sustainability, as well as educating pharmacists and billing professionals on billing opportunities. [...]
CONCLUSION: Pharmacist-led education significantly improved insulin injection techniques. Integrating pharmacists into routine diabetes care and reinforcing education is essential to sustain these improvements. These findings underscore that clinical pharmacy interventions make a tangible difference in improving healthcare outcomes. [...]
CONCLUSIONS: Current evidence confirms that pharmacist-led Interventions (including pharmacovigilance, medication counseling, pain management, therapeutic education, and medication reconciliation) effectively reduce adverse events and pain burden in cancer patients while enhancing treatment adherence and QoL. These findings substantiate the critical role of pharmacists as integral members of multidisciplinary teams in optimizing [...]
(1) Background: Pharmacist interventions are key to optimizing medication therapy and improving patient outcomes. The CLEO multidimensional tool assesses the clinical, economic, and organizational impact of these interventions, though its use in Portuguese hospital settings is limited. This study explored the predicted impact of pharmacist interventions in the Oncology Department [...]
CONCLUSION: This study provides the framework for assessing patient preferences for expanding pharmacy services in an underserved clinical setting. Clients report baseline trust in pharmacy services but report they do not believe a pharmacist could help with quit using illicit substances. Further studies are needed to fully quantify how pharmacists [...]
CONCLUSION: The Pharmacist Primary Care Certificate Training Program equipped pharmacists with the perceived skills, network, and confidence necessary to practice in outpatient primary care and be more competitive in the job market. However, there are specific barriers that influence long-term program impact, suggesting opportunities for practice transformation and further research. [...]
Home blood pressure (BP) monitoring (HBPM) is fundamental to effective hypertension management. Incorporating community pharmacists into care delivery, especially via hybrid case management methods utilizing digital telemonitoring, presents a promising strategy for enhancing BP control and patient self-management. Nonetheless, the efficacy of these interventions at a national level remains inadequately [...]
CONCLUSION: PIP is highly prevalent in NI care homes and was significantly reduced by a medicine optimisation pharmacist case management model. Clinical pharmacist input in long-term care is warranted to lessen medication-related harm for older adults. [...]
CONCLUSIONS: An interdisciplinary sedation team focused on pre-appointment planning for complex pediatric behavioral patients requiring a procedure in the outpatient setting was associated with reduced appointment and sedation times, a clinically and statistically significant finding, respectively. Future studies should focus on resource utilization and patient and caregiver satisfaction. [...]
BACKGROUND: Polypharmacy is a major and growing challenge for patient safety and health outcomes, and associated with inefficient use of resources. Management requires balancing therapeutic benefits and risks, aligned with clinical and patient priorities. High-quality evidence supporting current guidance for the management of polypharmacy is scarce. The aim of the [...]
Hypertension, a global health burden affecting over a billion individuals, significantly contributes to cardiovascular diseases and mortality. Despite the availability of effective antihypertensive therapies, medication adherence remains a critical challenge, particularly in low-resource settings. Pharmacist-led interventions have emerged as an effective strategy to enhance adherence and optimize blood pressure (BP) [...]
CONCLUSION: Exposure to diverse skin tone imagery in a Self-Care course overall positively affected students' ability and confidence in identifying conditions in SOC. [...]
Background: Clinical pharmacy services (CPSs) play a key role in ensuring medication safety, optimizing pharmacotherapy, and improving patient outcomes. While their benefits are well-documented globally, their specific impact within the Saudi healthcare system remains underexplored. Objective: This study aimed to evaluate the impact of pharmacist-led interventions in a tertiary medical [...]
CONCLUSIONS: The main conclusions highlight that pharmacist involvement in CKD screening improves public understanding of CKD risk factors, facilitates earlier initiation of treatment, and contributes to better long-term patient outcomes. [...]
CONCLUSION: Pharmacists contribute to the effectiveness of health-focused NGOs through diverse responsibilities and adaptable roles that extend beyond medication management. This study provides a foundational description of how pharmacists working in multinational NGOs perceive their roles, contributions, and professional experiences. Findings highlight key responsibilities, attributes needed for success, and challenges [...]
CONCLUSION: Pharmacist-led medication reconciliation, focusing on the best possible medication history collection and direct contact with physicians, significantly increased the identification and resolution of discrepancies, underlining its role in enhancing patient safety. [...]
The recurrence rate of stroke, particularly ischaemic stroke, is considered high, which highlights the importance of secondary stroke prevention. Pharmacists are becoming increasingly involved in poststroke care. Ease of public access to community pharmacists provides opportunities for pharmacists to educate patients about the significance of secondary stroke prevention. The literature [...]
CONCLUSIONS: Medicaid billing for pharmacist services remains in early stages of implementation in Virginia, with limited adoption among community-based pharmacists. Implementation barriers emerged across multiple domains including complex regulatory requirements, inadequate organizational support, and insufficient educational preparation. Targeted interventions addressing credentialing processes, technical infrastructure, and pharmacist education are essential to [...]
BACKGROUND: The scope of practice for community pharmacists is evolving globally. Policy drivers are to increase access to primary care, due to the lack of accessibility to general medical practitioners or inappropriate demand on emergency departments. Most implementation studies in this space have reported on determinants for pharmacist prescribing services. [...]
CONCLUSIONS: Pharmacist-led hypertension management under a CPA significantly improves BP control, time to goal, medication adherence, and reduces hospitalizations compared to physician-only care in a rural, underserved FQHC setting. [...]
CONCLUSION: Pharmacist interventions improve BP control in patients with diabetes and hypertension. [...]
CONCLUSION: This study demonstrates that prescriptions made by clinical pharmacists in collaboration with GPs, as specified in the CPA, improved PROs and clinical outcomes for predefined conditions. [...]
Improving adherence enhances therapeutic outcomes in hemodialysis patients; several approaches, including behavioral interventions, were utilized to improve adherence. Examine the effect of a pharmacist-led behavioral change technique (PL-BCT) intervention on hemodialysis patients' adherence to their complex therapeutic regimen and physical indices. Parallel-group, cluster-randomized, controlled trial, in which the patients were [...]
CONCLUSION: Pharmacist-led FIB-4 screening allowed the pharmacist to identify and subsequently provide appropriate pharmacotherapy recommendations for older adults with elevated risk for advanced fibrosis. Pharmacists providing annual wellness visits or chronic disease management are well positioned to provide screening, education, and treatment recommendations for MASLD. [...]
CONCLUSION: Pharmacist-interpreted pt-qPCR significantly improves pathogen detection and optimizes antimicrobial therapy in LRTI patients. Its clinical use may enhance antibiotic stewardship, reduce ICU burden, and support precision medicine in respiratory infections. [...]
CONCLUSION: The ASPIRE intervention was successfully implemented and considered feasible and acceptable by the stakeholders, highlighting its potential to improve care for geriatric patients. The high level of implementation provide a strong basis for the further evaluation of its effectiveness. [...]
CONCLUSION: Several factors were identified that influenced successful implementation and delivery of pharmacist prescribing services for patients with mental illness in community care. Improved education and training in mental health along with a clearer definition of the pharmacist prescribing role may support optimal service delivery. Future work evaluating pharmacist prescribing [...]
CONCLUSION: Pharmacist-led electrolyte ordering in parenteral nutrition was associated with substantially fewer electrolyte abnormalities but no difference in arrhythmias, deaths, or hospital length of stay. Further research is needed to explore electrolyte-relevant outcomes for patients receiving parenteral nutrition. [...]
CONCLUSION: Remote pharmaceutical services delivered via a follow-up app effectively reduce the incidence of severe adverse drug reactions and improve medication knowledge, adherence, and quality of life in non-metastatic breast cancer patients. This model provides a viable new approach for out-of-hospital management and highlights the value of pharmacists in the [...]
CONCLUSION: Pharmacist-led chemotherapy counseling significantly improved psychological well-being and HRQoL among oncology patients, highlighting the valuable role of pharmacists in comprehensive cancer care, especially in low-resource settings. [...]
In this multicenter, nonrandomised comparative study, we evaluated the potential effectiveness of a program to promote the safe use of dipeptidyl peptidase-4 (DPP-4) inhibitors led by community pharmacists. The program facilitated early detection of gastrointestinal adverse events (GIAEs) in patients newly prescribed DPP-4 inhibitors and facilitated timely communication with physicians. [...]
Polypharmacy is prevalent in older people residing in care homes. Deprescribing, reducing or stopping harmful or unnecessary medicines, leads to improvements in patient- and health-system-orientated outcomes. This study identified the barriers and enablers to pharmacists proactively deprescribing in United Kingdon care homes. It draws on methods from behavioural science. Twenty-nine [...]
CONCLUSION: Remote pharmacist-led care management increased BP control across racial subpopulations and improved medication adherence and acute care service utilization. [...]
Chronic obstructive pulmonary disease (COPD), predicted to become the third leading cause of death by 2030 with 3 million annual fatalities, imposes significant health and economic burdens due to its diverse respiratory conditions. Effective management strategies include symptom relief, disease progression control, and exacerbation prevention through interventions like smoking cessation, [...]
CONCLUSION: This study demonstrates that interventions by clinical pharmacists during the medication review process effectively reduced the number of medications, PIMs, and DDIs while significantly improving adherence to treatment guidelines. [...]
CONCLUSIONS: Pharmacist-led antibiotic stewardship effectively optimised antibiotic use in geriatric neurology patients, reducing unnecessary broad-spectrum antibiotic exposure and improving treatment efficiency. [...]
INTRODUCTION: Many psychotropic drugs potentially prolong the QTc interval. The aim of this study was to investigate the feasibility of the pharmacist-supported implementation of a new local guideline for QTc monitoring at a psychiatric department and to gather preliminary data on the effectiveness of this intervention. [...]
CONCLUSIONS: This case study demonstrates that interventions by a clinical pharmacist prescriber during the medication review process resulted in improved clinical outcomes in the treatment of depression, as well as enhanced quality of life. It represents an important contribution to the development of pharmacist prescribing roles in depression management within [...]
A psychiatric pharmacist can play a critical role in addressing health disparities in black patients by managing both psychiatric and nonpsychiatric conditions. Black patients experience disparities in the treatment of both hypertension and mental health disorders, highlighting the need for innovative care models. This paper describes the integration of a [...]
CONCLUSION: Clinical pharmacist-driven AMSP can be effectively implemented irrespective of the cultural and geographical setting due to their ability to improve prescription practices. [...]
While deprescribing benzodiazepines and related drugs (BZRDs) is crucial for preventing prolonged use and their associated adverse effects, it presents challenges from a healthcare perspective, because of limited resources and time. Recently, a pharmacist-led deprescribing of BZRDs in the treatment of insomnia was introduced in Helsinki's primary care health centres. [...]
Medication reconciliation was adopted as a National Patient Safety Goal by the Joint Commission in 2005 and is now standard practice across care settings. More recently, the concept of medication optimization has gained attention, recognizing that safe medication use requires more than reconciliation alone. Home healthcare (HHC) is one setting [...]
No abstract [...]
CONCLUSION: A pharmacist-led anticoagulation management model based on the PEAC framework significantly reduced perioperative VTE incidence without increasing adverse events. These findings support broader implementation of proactive, pharmacist-driven strategies to improve thromboprophylaxis quality in orthopedic surgery. [...]
With the advancement of digital technologies, pharmacist-led digital health interventions (DHI) have emerged as a promising strategy to improve hypertension management. This systematic review evaluated randomized controlled trials (RCTs) published from December 1996 to May 2024, identified via PubMed by incorporating key concepts including DHIs, pharmaceutical care, and hypertension. The [...]
CONCLUSIONS: This study demonstrated that the family pharmacist system improved TDDI prevention among underage individuals. However, its effectiveness was consistent regardless of the characteristics related to the utilization of the family pharmacist system, indicating that the trend of positively applying the system to those with these characteristics was not supported. [...]
Optimal guideline-directed medical therapy (GDMT) can reduce mortality, unplanned hospital admissions and improve quality of life for patients suffering from heart failure (HF). However, GDMT remains underused in primary care. Only a minority of patients on HF registers receive optimal GDMT in the UK. This suboptimal care is compounded by [...]
CONCLUSION: The findings suggest that community pharmacist-led interventions targeting cardiovascular risk reduction in patients with T2DM are both clinically effective and cost-efficient. Incorporating pharmacists into diabetes care programs may significantly improve cardiovascular outcomes while reducing long-term healthcare costs in Iran. [...]
Background/Objectives: Pharmacists are highly accessible healthcare providers who have frequent, repeated contact with diverse patient populations. They are poised to offer expanded and comprehensive healthcare, including mental health services. One potential barrier to this is a lack of knowledge, confidence, or training in mental health, which may be overcome with [...]
CONCLUSIONS: There exists a critical necessity for pharmacists to augment their comprehension of the medications utilized in smoking cessation. Such enhancement is essential to improve their practices and, consequently, to attain superior outcomes in supporting individuals in their efforts to quit smoking. [...]
Pharmacist-led transitions of care (TOC) services decrease preventable hospital readmission. TOC service implementation assessment can inform translation to real-world settings. The purpose of this study was to evaluate the implementation of a TOC service for patients with multiple admissions at a regional hospital using the RE-AIM framework. In this quasi-experimental, [...]
Medication discrepancies at hospital admission are common and may lead to adverse outcomes. Medication reconciliation is a critical process for minimizing medication discrepancies and medication errors at the time of hospital admission. This study aimed to evaluate the role of clinical pharmacists in identifying pharmacotherapy-related issues upon patient admission in [...]
CONCLUSION: In three Norwegian EDs, junior physicians' work time was predominantly spent on non-medication-related tasks, with only 8.7% dedicated to medication-related tasks. The introduction of clinical pharmacists did not significantly impact junior physicians' overall work-time distribution. Further research should investigate pharmacists' impact on ED care quality and efficiency. [...]
Polypharmacy in older adults increases risks of adverse drug reactions (ADRs), hospitalisations, and mortality. Pharmacist-led interventions using validated tools (e.g., STOPP/START, MAI, STOPPFrail) aim to optimise prescribing, yet their impact on clinical and economic outcomes in UK/Ireland health systems remains underexplored. This systematic review aimed to critically assess the impact [...]
CONCLUSION: The ACOP program represents a promising strategy to enhance medication management in RACHs. However, implementation on a large scale necessitates a thoughtful consideration of various interconnected factors at the individual, organisation and policy levels that may affect its uptake, adoptability, and long-term sustainability. This has implications for policymakers and [...]
The health of Canadians in correctional facilities is poor when compared with the general population. Pharmacists effectively manage chronic illness and minor ailments; pharmacist-led prescriber clinics are being introduced in the community to improve access to care. However, there are no data on this model in correctional facilities. This article [...]
Pain remains one of the most common reasons that individuals seek healthcare. Despite advances in pain care and an improved understanding of the harms associated with opioid use, there is still considerable reliance on opioid medications for treating both acute and chronic pain. With the implementation of guidelines emphasizing opioid [...]
CONCLUSION: Pharmacist interventions may significantly impact the health outcomes of patients with schizophrenia or BAD, but more high-quality RCTs are needed to solidify these findings. [...]
BackgroundPharmacist-led multidisciplinary care may enhance diabetes self-management, yet evidence from Taiwan is limited. This study evaluates the impact of such interventions on health literacy, medication adherence, and clinical outcomes in patients with type 2 diabetes.MethodsA quasi-experimental pretest-posttest study was conducted at Taipei City Hospital (April to December 2021) with 70 [...]
CONCLUSIONS: EMP presence during AIS management is associated with a reduction in fibrinolytic DTN time compared to no EMP presence. These findings highlight the importance of EMPs in optimizing patient outcomes related to stroke care. [...]
CONCLUSIONS: There was no difference in the rate of anti-Xa concentrations that were in goal between groups. This likely stemmed from the use of the same dose adjustment guideline among both groups. This underscores the equal quality of care provided by pharmacists in achieving optimal anticoagulation and positive outcomes. [...]
INTRODUCTION: Pharmacist prescribing has evolved to meet healthcare system needs, but the effectiveness, mechanisms and contextual factors influencing education programmes remain poorly understood. Realist approaches are fairly novel in pharmacy practice research. This realist synthesis aims to answer the question: to what extent do pharmacy prescribing education programs work (or [...]
CONCLUSION: The prevalence of prematriculation programs in US colleges/schools of pharmacy appears to be growing. However, few institutions reported a clearly positive impact of these interventions on student success outcomes. More data-driven research is needed to fully assess the effectiveness of prematriculation programs in supporting student pharmacists' success. [...]
Background: The use of warfarin is complicated by a narrow therapeutic window, requiring close monitoring to prevent serious adverse events. Literature has shown that pharmacist-led warfarin management improves patient outcomes and decreases hospitalization length of stay. This study assessed the impact of the recently implemented pharmacist-driven warfarin consult service at [...]
CONCLUSIONS: Our study revealed that a pharmacist-led genotype-guided warfarin dosing strategy could improve the effectiveness of anticoagulant therapy for valve replacement operations. [...]
No abstract [...]
CONCLUSIONS: The clinical pharmacist-led deprescribing intervention, designed to reduce the use of PIMs not only significantly decreased the number of prescribed drugs, but also markedly reduced the incidence of ADRs among older inpatients with hip fractures. [...]
BackgroundImmunocompromised patients undergoing cancer therapy are at increased risk for severe infections such as rabies. Coordinating rabies post-exposure prophylaxis (PEP) with ongoing treatment requires careful planning.Case PresentationA 73-year-old female with metastatic breast cancer, scheduled to begin second-line chemotherapy, sustained a WHO Category 3 cat scratch injury. A clinical pharmacist collaborated [...]
CONCLUSION: Pharmacist-led interventions enhance medication adherence in mean PDC and adherence rate. These consistent effects across different durations and delivery methods show their adaptability and scalability in clinical settings, highlighting their value in real-world pharmacy practice. [...]
INTRODUCTION: Transitions from the emergency department (ED) to home are high-risk periods for medication-related harm. Pharmacist-led interventions during this period may improve medication safety and care continuity, yet co-design approaches to develop such interventions remain underused. The aim of this study is to co-design a pharmacist-led transition of care programme [...]
CONCLUSION: Pharmacist-led anti-infective consultations demonstrate efficacy in enhancing infection treatment outcomes and curbing antimicrobial expenditures, providing actionable evidence for scaling antimicrobial stewardship programs in one DRG-based hospital in China. [...]
CONCLUSION: Pharmacists remain accessible healthcare providers for individuals with diabetes, but deficits in CGM counseling and patient education in community pharmacies exist. Barriers may include low pharmacist comfort with CGM devices and potential lack of familiarity based on the type of device a patient is using. [...]
CONCLUSION: Integrating an oncology pharmacist into hematology-oncology clinics reduces ADRs and improves the detection and prevention of potentially serious MEs. [...]
CONCLUSION/LESSONS LEARNED: Opioid deprescribing clinic was time-intensive and patients required close monitoring for implementation of patient-specific opioid deprescribing plans. [...]
CONCLUSION: The new model illustrates how pharmacists can support GPs. New program theory regards the importance of compatible perspectives between pharmacists and GPs on appropriate polypharmacy work, i.e., 'shared mental models', the ways GPs can develop their mental models when interacting with pharmacists, and the usefulness of relational work when [...]
CONCLUSIONS: Most community pharmacists in the United States would be willing to integrate PharmFIT into their current workflows. Training in how to deliver fecal immunochemical testing and preparation for the coordination of test results and follow-up care should be completed prior to implementing PharmFIT. [...]
CONCLUSION: Findings highlight a growing trend of social media-driven decisions regarding weight-loss medication use and the associated risks of unregulated online-purchases. Pharmacists play a crucial role in mitigating adverse outcomes by promoting drug safety and adherence. Policy efforts should focus on enhancing regulations of over-the-counter online sales, strengthening pharmacist-led patient [...]
CONCLUSIONS: Our analysis suggests that the involvement of pharmacists in the context of emergency cardiac or trauma resuscitations may benefit direct patient outcomes and indirect outcomes. [...]
Problem-solving courts (PSCs) are major diversionary programs in the United States (U.S.) criminal legal system, mandating substance use and mental health treatment as an alternative to incarceration. While they reduce recidivism, their impact on clinical outcomes remains uncertain. A significant challenge is ensuring participants have access to and remain in [...]
CONCLUSION: Gamification offers a novel approach to enhancing medication education for adolescent transplant patients. The involvement of pharmacists and pharmacy students in developing and delivering gamified education can support patient engagement and transition to adult care. Future research is needed to evaluate the impact of gamification on clinical outcomes, including [...]
CONCLUSION: The project developed a standardized, reproducible methodology to implement and validate clinical outcome measures for acute care pharmacists. This methodology was successful in measuring outputs for the 3 different acute care pilot areas. [...]
CONCLUSION: By employing the PDSA methodology, a standard and sustainable process was created to identify service-specific clinical outcomes for acute care services. The second phase of the research explored validation of identified outcomes and reporting methodologies within the electronic medical record. [...]
INTRODUCTION: The increasing emergence of bacteria resistant to antibiotic treatments has become a global public health concern and one of the leading causes of death worldwide. This growing threat demands urgent and coordinated action from health systems across the globe. A key driver of antimicrobial resistance is the inappropriate and [...]
Purpose: This study serves to evaluate the potential benefit of pharmacist intervention in ensuring appropriate treatment of urinary tract infections (UTI) in adult patients in a community hospital. Methods: This was a single-center, quasi-experimental design, institutional review board (IRB)-approved study comparing antimicrobial use and UTI treatment guidance adherence before (11/2021-1/2022) [...]
CONCLUSIONS AND RELEVANCE: In this randomized clinical trial, the AR-PRISE intervention significantly improved AR symptom control (TNSS for the past 2 weeks) compared with standard care over 180 days but did not show significant effects on other coprimary outcomes (AR knowledge, TNSS for the past 12 hours, medication adherence, or [...]
CONCLUSION: The DMTAC programme in public health clinics across Johor, Malaysia, significantly improves HbA1c levels, fasting blood glucose levels, lipid profiles, BPs and medication understanding, with DMTAC pharmacists playing a key role in supporting multidisciplinary teams through targeted interventions and counselling. [...]
CONCLUSION: Pharmacist-led interventions show promise in improving COPD health outcomes, reinforcing the pharmacist's role in disease management. However, the current evidence base is limited by methodological weaknesses, highlighting the need for high-quality research to validate and expand these findings. [...]
CONCLUSION: Pharmacist review of patients in an outpatient vascular clinic is a likely effective strategy to improve prescribing rates of guideline adherent statin therapy and smoking cessation service provision. [...]
Allergic rhinitis (AR) and asthma are common respiratory disorders that often occur together, affecting quality of life and increasing healthcare expenses of patients. These chronic illnesses are often managed without medical supervision, creating distinct challenges. A lack of resources can limit regular follow-up, which in turn promotes disease mismanagement and [...]
CONCLUSION: This study offers significant insights into the prevalence, clinical management, and outcomes of HADRs associated with hydroxyurea therapy in pediatric SCD patients. The findings underscore the need for proactive management approaches to optimize treatment outcomes and ensure patient safety. [...]
BACKGROUND: Guideline-directed medical therapy (GDMT) is a cornerstone in the management of congestive heart failure, offering well-documented benefits in reducing mortality and morbidity. However, despite strong clinical evidence, many eligible patients do not receive optimal GDMT during hospitalization. [...]
CONCLUSION: Collaborative prescribing models are the most commonly described PP models used in cancer services. There is potential for expanding pharmacists' scope of practice in cancer services where this is not routine. [...]
CONCLUSION: Pharmacist-led post-prescription interventions within an established AMS program effectively identified clinically relevant misuse of restricted antimicrobials. Targeted actions on key agents enable high-impact optimization, supported by strong acceptance and cost-saving potential - thereby enhancing stewardship efforts, guiding improvements in diagnostics, and prescribing behavior. [...]
CONCLUSION: The findings suggested that pharmacist involvement in gout management can considerably enhance disease control and improve the overall quality of life for patients. Further research is warranted to identify the most effective components of pharmacist-led interventions and to evaluate their effect on gout outcomes. [...]
CONCLUSIONS: By utilizing the MHC model, pharmacists may be better able to address health gaps while leveraging existing resources, and providing services tailored to the needs of the patients within a community. These findings may be used as a guide for the development, implementation, and operation of current and future [...]
BACKGROUND: Heart failure (HF) remains a major global health challenge. Guideline-directed medical therapy can effectively reduce mortality and hospitalizations; however, persistent medication nonadherence hinders its real-world impact. Although recent guidelines emphasize the pivotal role of pharmacists in supporting medication adherence, the mechanisms through which pharmacist-led patient education influences medication adherence [...]
CONCLUSION: The pharmacist-led DSME program was effective in enhancing glycemic control, diabetes knowledge, self-management behaviors, and HRQoL in patients with T2DM. Findings from subgroup analyses underscore the potential of tailored pharmacist-led interventions to optimize outcomes in high-risk populations. [...]
CONCLUSIONS: The implementation of a structured algorithm for penicillin allergy reassessment in emergency settings is effective and safe. Its application facilitates antibiotic optimization, improves patient safety, and reduces broad-spectrum antibiotic use. This study highlights the role of hospital pharmacists in drug allergy management and antimicrobial stewardship. [...]
CONCLUSION: A variety of multifaced approaches to pharmacist-led ToC services have been evaluated within many studies, reporting favourable effects on outcomes for patients with cardiovascular disease. Tailoring ToC services to specific patient populations and settings, targeting activities to high-risk patients, and a multidisciplinary approach, are important to optimise ToC and [...]
Pharmacist & Outcomes – Open Acess (Free PDF)
CONCLUSION: Pharmacist-led education significantly improved insulin injection techniques. Integrating pharmacists into routine diabetes care and reinforcing education is essential to sustain these improvements. These findings underscore that clinical pharmacy interventions make a tangible difference in improving healthcare outcomes. [...]
(1) Background: Pharmacist interventions are key to optimizing medication therapy and improving patient outcomes. The CLEO multidimensional tool assesses the clinical, economic, and organizational impact of these interventions, though its use in Portuguese hospital settings is limited. This study explored the predicted impact of pharmacist interventions in the Oncology Department [...]
BACKGROUND: Polypharmacy is a major and growing challenge for patient safety and health outcomes, and associated with inefficient use of resources. Management requires balancing therapeutic benefits and risks, aligned with clinical and patient priorities. High-quality evidence supporting current guidance for the management of polypharmacy is scarce. The aim of the [...]
Background: Clinical pharmacy services (CPSs) play a key role in ensuring medication safety, optimizing pharmacotherapy, and improving patient outcomes. While their benefits are well-documented globally, their specific impact within the Saudi healthcare system remains underexplored. Objective: This study aimed to evaluate the impact of pharmacist-led interventions in a tertiary medical [...]
CONCLUSIONS: The main conclusions highlight that pharmacist involvement in CKD screening improves public understanding of CKD risk factors, facilitates earlier initiation of treatment, and contributes to better long-term patient outcomes. [...]
CONCLUSION: Pharmacists contribute to the effectiveness of health-focused NGOs through diverse responsibilities and adaptable roles that extend beyond medication management. This study provides a foundational description of how pharmacists working in multinational NGOs perceive their roles, contributions, and professional experiences. Findings highlight key responsibilities, attributes needed for success, and challenges [...]
CONCLUSION: Pharmacist-led medication reconciliation, focusing on the best possible medication history collection and direct contact with physicians, significantly increased the identification and resolution of discrepancies, underlining its role in enhancing patient safety. [...]
The recurrence rate of stroke, particularly ischaemic stroke, is considered high, which highlights the importance of secondary stroke prevention. Pharmacists are becoming increasingly involved in poststroke care. Ease of public access to community pharmacists provides opportunities for pharmacists to educate patients about the significance of secondary stroke prevention. The literature [...]
BACKGROUND: The scope of practice for community pharmacists is evolving globally. Policy drivers are to increase access to primary care, due to the lack of accessibility to general medical practitioners or inappropriate demand on emergency departments. Most implementation studies in this space have reported on determinants for pharmacist prescribing services. [...]
CONCLUSIONS: Pharmacist-led hypertension management under a CPA significantly improves BP control, time to goal, medication adherence, and reduces hospitalizations compared to physician-only care in a rural, underserved FQHC setting. [...]
CONCLUSION: Pharmacist interventions improve BP control in patients with diabetes and hypertension. [...]
CONCLUSION: This study demonstrates that prescriptions made by clinical pharmacists in collaboration with GPs, as specified in the CPA, improved PROs and clinical outcomes for predefined conditions. [...]
Improving adherence enhances therapeutic outcomes in hemodialysis patients; several approaches, including behavioral interventions, were utilized to improve adherence. Examine the effect of a pharmacist-led behavioral change technique (PL-BCT) intervention on hemodialysis patients' adherence to their complex therapeutic regimen and physical indices. Parallel-group, cluster-randomized, controlled trial, in which the patients were [...]
CONCLUSION: Several factors were identified that influenced successful implementation and delivery of pharmacist prescribing services for patients with mental illness in community care. Improved education and training in mental health along with a clearer definition of the pharmacist prescribing role may support optimal service delivery. Future work evaluating pharmacist prescribing [...]
CONCLUSION: Pharmacist-interpreted pt-qPCR significantly improves pathogen detection and optimizes antimicrobial therapy in LRTI patients. Its clinical use may enhance antibiotic stewardship, reduce ICU burden, and support precision medicine in respiratory infections. [...]
CONCLUSION: Remote pharmaceutical services delivered via a follow-up app effectively reduce the incidence of severe adverse drug reactions and improve medication knowledge, adherence, and quality of life in non-metastatic breast cancer patients. This model provides a viable new approach for out-of-hospital management and highlights the value of pharmacists in the [...]
CONCLUSION: Pharmacist-led chemotherapy counseling significantly improved psychological well-being and HRQoL among oncology patients, highlighting the valuable role of pharmacists in comprehensive cancer care, especially in low-resource settings. [...]
In this multicenter, nonrandomised comparative study, we evaluated the potential effectiveness of a program to promote the safe use of dipeptidyl peptidase-4 (DPP-4) inhibitors led by community pharmacists. The program facilitated early detection of gastrointestinal adverse events (GIAEs) in patients newly prescribed DPP-4 inhibitors and facilitated timely communication with physicians. [...]
Polypharmacy is prevalent in older people residing in care homes. Deprescribing, reducing or stopping harmful or unnecessary medicines, leads to improvements in patient- and health-system-orientated outcomes. This study identified the barriers and enablers to pharmacists proactively deprescribing in United Kingdon care homes. It draws on methods from behavioural science. Twenty-nine [...]
Chronic obstructive pulmonary disease (COPD), predicted to become the third leading cause of death by 2030 with 3 million annual fatalities, imposes significant health and economic burdens due to its diverse respiratory conditions. Effective management strategies include symptom relief, disease progression control, and exacerbation prevention through interventions like smoking cessation, [...]
CONCLUSION: This study demonstrates that interventions by clinical pharmacists during the medication review process effectively reduced the number of medications, PIMs, and DDIs while significantly improving adherence to treatment guidelines. [...]
INTRODUCTION: Many psychotropic drugs potentially prolong the QTc interval. The aim of this study was to investigate the feasibility of the pharmacist-supported implementation of a new local guideline for QTc monitoring at a psychiatric department and to gather preliminary data on the effectiveness of this intervention. [...]
CONCLUSIONS: This case study demonstrates that interventions by a clinical pharmacist prescriber during the medication review process resulted in improved clinical outcomes in the treatment of depression, as well as enhanced quality of life. It represents an important contribution to the development of pharmacist prescribing roles in depression management within [...]
A psychiatric pharmacist can play a critical role in addressing health disparities in black patients by managing both psychiatric and nonpsychiatric conditions. Black patients experience disparities in the treatment of both hypertension and mental health disorders, highlighting the need for innovative care models. This paper describes the integration of a [...]
CONCLUSION: Clinical pharmacist-driven AMSP can be effectively implemented irrespective of the cultural and geographical setting due to their ability to improve prescription practices. [...]
While deprescribing benzodiazepines and related drugs (BZRDs) is crucial for preventing prolonged use and their associated adverse effects, it presents challenges from a healthcare perspective, because of limited resources and time. Recently, a pharmacist-led deprescribing of BZRDs in the treatment of insomnia was introduced in Helsinki's primary care health centres. [...]
Medication reconciliation was adopted as a National Patient Safety Goal by the Joint Commission in 2005 and is now standard practice across care settings. More recently, the concept of medication optimization has gained attention, recognizing that safe medication use requires more than reconciliation alone. Home healthcare (HHC) is one setting [...]
No abstract [...]
With the advancement of digital technologies, pharmacist-led digital health interventions (DHI) have emerged as a promising strategy to improve hypertension management. This systematic review evaluated randomized controlled trials (RCTs) published from December 1996 to May 2024, identified via PubMed by incorporating key concepts including DHIs, pharmaceutical care, and hypertension. The [...]
CONCLUSIONS: This study demonstrated that the family pharmacist system improved TDDI prevention among underage individuals. However, its effectiveness was consistent regardless of the characteristics related to the utilization of the family pharmacist system, indicating that the trend of positively applying the system to those with these characteristics was not supported. [...]
Optimal guideline-directed medical therapy (GDMT) can reduce mortality, unplanned hospital admissions and improve quality of life for patients suffering from heart failure (HF). However, GDMT remains underused in primary care. Only a minority of patients on HF registers receive optimal GDMT in the UK. This suboptimal care is compounded by [...]
CONCLUSION: The findings suggest that community pharmacist-led interventions targeting cardiovascular risk reduction in patients with T2DM are both clinically effective and cost-efficient. Incorporating pharmacists into diabetes care programs may significantly improve cardiovascular outcomes while reducing long-term healthcare costs in Iran. [...]
Background/Objectives: Pharmacists are highly accessible healthcare providers who have frequent, repeated contact with diverse patient populations. They are poised to offer expanded and comprehensive healthcare, including mental health services. One potential barrier to this is a lack of knowledge, confidence, or training in mental health, which may be overcome with [...]
CONCLUSION: In three Norwegian EDs, junior physicians' work time was predominantly spent on non-medication-related tasks, with only 8.7% dedicated to medication-related tasks. The introduction of clinical pharmacists did not significantly impact junior physicians' overall work-time distribution. Further research should investigate pharmacists' impact on ED care quality and efficiency. [...]
CONCLUSIONS: There exists a critical necessity for pharmacists to augment their comprehension of the medications utilized in smoking cessation. Such enhancement is essential to improve their practices and, consequently, to attain superior outcomes in supporting individuals in their efforts to quit smoking. [...]
Pharmacist-led transitions of care (TOC) services decrease preventable hospital readmission. TOC service implementation assessment can inform translation to real-world settings. The purpose of this study was to evaluate the implementation of a TOC service for patients with multiple admissions at a regional hospital using the RE-AIM framework. In this quasi-experimental, [...]
Medication discrepancies at hospital admission are common and may lead to adverse outcomes. Medication reconciliation is a critical process for minimizing medication discrepancies and medication errors at the time of hospital admission. This study aimed to evaluate the role of clinical pharmacists in identifying pharmacotherapy-related issues upon patient admission in [...]
Polypharmacy in older adults increases risks of adverse drug reactions (ADRs), hospitalisations, and mortality. Pharmacist-led interventions using validated tools (e.g., STOPP/START, MAI, STOPPFrail) aim to optimise prescribing, yet their impact on clinical and economic outcomes in UK/Ireland health systems remains underexplored. This systematic review aimed to critically assess the impact [...]
CONCLUSIONS: There was no difference in the rate of anti-Xa concentrations that were in goal between groups. This likely stemmed from the use of the same dose adjustment guideline among both groups. This underscores the equal quality of care provided by pharmacists in achieving optimal anticoagulation and positive outcomes. [...]
INTRODUCTION: Pharmacist prescribing has evolved to meet healthcare system needs, but the effectiveness, mechanisms and contextual factors influencing education programmes remain poorly understood. Realist approaches are fairly novel in pharmacy practice research. This realist synthesis aims to answer the question: to what extent do pharmacy prescribing education programs work (or [...]
Background: The use of warfarin is complicated by a narrow therapeutic window, requiring close monitoring to prevent serious adverse events. Literature has shown that pharmacist-led warfarin management improves patient outcomes and decreases hospitalization length of stay. This study assessed the impact of the recently implemented pharmacist-driven warfarin consult service at [...]
CONCLUSIONS: The clinical pharmacist-led deprescribing intervention, designed to reduce the use of PIMs not only significantly decreased the number of prescribed drugs, but also markedly reduced the incidence of ADRs among older inpatients with hip fractures. [...]
INTRODUCTION: Transitions from the emergency department (ED) to home are high-risk periods for medication-related harm. Pharmacist-led interventions during this period may improve medication safety and care continuity, yet co-design approaches to develop such interventions remain underused. The aim of this study is to co-design a pharmacist-led transition of care programme [...]
CONCLUSION: Pharmacist-led anti-infective consultations demonstrate efficacy in enhancing infection treatment outcomes and curbing antimicrobial expenditures, providing actionable evidence for scaling antimicrobial stewardship programs in one DRG-based hospital in China. [...]
CONCLUSION/LESSONS LEARNED: Opioid deprescribing clinic was time-intensive and patients required close monitoring for implementation of patient-specific opioid deprescribing plans. [...]
CONCLUSION: The new model illustrates how pharmacists can support GPs. New program theory regards the importance of compatible perspectives between pharmacists and GPs on appropriate polypharmacy work, i.e., 'shared mental models', the ways GPs can develop their mental models when interacting with pharmacists, and the usefulness of relational work when [...]
CONCLUSIONS: Most community pharmacists in the United States would be willing to integrate PharmFIT into their current workflows. Training in how to deliver fecal immunochemical testing and preparation for the coordination of test results and follow-up care should be completed prior to implementing PharmFIT. [...]
CONCLUSION: Findings highlight a growing trend of social media-driven decisions regarding weight-loss medication use and the associated risks of unregulated online-purchases. Pharmacists play a crucial role in mitigating adverse outcomes by promoting drug safety and adherence. Policy efforts should focus on enhancing regulations of over-the-counter online sales, strengthening pharmacist-led patient [...]
CONCLUSIONS: Our analysis suggests that the involvement of pharmacists in the context of emergency cardiac or trauma resuscitations may benefit direct patient outcomes and indirect outcomes. [...]
INTRODUCTION: The increasing emergence of bacteria resistant to antibiotic treatments has become a global public health concern and one of the leading causes of death worldwide. This growing threat demands urgent and coordinated action from health systems across the globe. A key driver of antimicrobial resistance is the inappropriate and [...]
Purpose: This study serves to evaluate the potential benefit of pharmacist intervention in ensuring appropriate treatment of urinary tract infections (UTI) in adult patients in a community hospital. Methods: This was a single-center, quasi-experimental design, institutional review board (IRB)-approved study comparing antimicrobial use and UTI treatment guidance adherence before (11/2021-1/2022) [...]
CONCLUSIONS AND RELEVANCE: In this randomized clinical trial, the AR-PRISE intervention significantly improved AR symptom control (TNSS for the past 2 weeks) compared with standard care over 180 days but did not show significant effects on other coprimary outcomes (AR knowledge, TNSS for the past 12 hours, medication adherence, or [...]
CONCLUSION: The DMTAC programme in public health clinics across Johor, Malaysia, significantly improves HbA1c levels, fasting blood glucose levels, lipid profiles, BPs and medication understanding, with DMTAC pharmacists playing a key role in supporting multidisciplinary teams through targeted interventions and counselling. [...]
CONCLUSION: Pharmacist-led interventions show promise in improving COPD health outcomes, reinforcing the pharmacist's role in disease management. However, the current evidence base is limited by methodological weaknesses, highlighting the need for high-quality research to validate and expand these findings. [...]
CONCLUSION: This study offers significant insights into the prevalence, clinical management, and outcomes of HADRs associated with hydroxyurea therapy in pediatric SCD patients. The findings underscore the need for proactive management approaches to optimize treatment outcomes and ensure patient safety. [...]
Allergic rhinitis (AR) and asthma are common respiratory disorders that often occur together, affecting quality of life and increasing healthcare expenses of patients. These chronic illnesses are often managed without medical supervision, creating distinct challenges. A lack of resources can limit regular follow-up, which in turn promotes disease mismanagement and [...]
BACKGROUND: Guideline-directed medical therapy (GDMT) is a cornerstone in the management of congestive heart failure, offering well-documented benefits in reducing mortality and morbidity. However, despite strong clinical evidence, many eligible patients do not receive optimal GDMT during hospitalization. [...]
CONCLUSION: Collaborative prescribing models are the most commonly described PP models used in cancer services. There is potential for expanding pharmacists' scope of practice in cancer services where this is not routine. [...]
CONCLUSION: The findings suggested that pharmacist involvement in gout management can considerably enhance disease control and improve the overall quality of life for patients. Further research is warranted to identify the most effective components of pharmacist-led interventions and to evaluate their effect on gout outcomes. [...]
CONCLUSIONS: By utilizing the MHC model, pharmacists may be better able to address health gaps while leveraging existing resources, and providing services tailored to the needs of the patients within a community. These findings may be used as a guide for the development, implementation, and operation of current and future [...]
BACKGROUND: Heart failure (HF) remains a major global health challenge. Guideline-directed medical therapy can effectively reduce mortality and hospitalizations; however, persistent medication nonadherence hinders its real-world impact. Although recent guidelines emphasize the pivotal role of pharmacists in supporting medication adherence, the mechanisms through which pharmacist-led patient education influences medication adherence [...]
CONCLUSIONS: The implementation of a structured algorithm for penicillin allergy reassessment in emergency settings is effective and safe. Its application facilitates antibiotic optimization, improves patient safety, and reduces broad-spectrum antibiotic use. This study highlights the role of hospital pharmacists in drug allergy management and antimicrobial stewardship. [...]
CONCLUSION: A variety of multifaced approaches to pharmacist-led ToC services have been evaluated within many studies, reporting favourable effects on outcomes for patients with cardiovascular disease. Tailoring ToC services to specific patient populations and settings, targeting activities to high-risk patients, and a multidisciplinary approach, are important to optimise ToC and [...]
Cardiovascular (CV) disease (CVD) is the leading cause of death worldwide. The risk factors contributing to CVD development have been well known for decades, but treatment gaps persist. Pharmacists are frontline primary healthcare providers whose interventions to lower CV risk are supported by rigorous evidence. However, efforts to support the [...]
Pulmonary tuberculosis (TB) remains a significant global health concern, particularly in low- and middle-income countries, where treatment adherence is critical to improving patient outcomes and mitigating drug resistance. In Malaysia, challenges in adherence to TB treatment regimens continue to hinder disease control efforts. This study protocol outlines a pharmacist-led educational [...]
CONCLUSION: Pharmacist-led MRs in a pain clinic have demonstrated significant clinical impact. By identifying predictors of effective interventions, this study provides insights for targeting patients who may benefit most. Furthermore, the recognition of pharmacists' expertise by the interdisciplinary team supports the integration of pharmacy-led initiatives to enhance collaborative care and [...]
Background: The effective management of psychotic and bipolar disorders in tertiary care can improve patient outcomes, yet the role of clinical pharmacists in optimising psychotropic medication use remains underexplored in South Africa. This study aims to investigate the role and interventions of clinical pharmacists in managing psychotic and bipolar disorders [...]
CONCLUSIONS: A dedicated pharmacist comanagement telehealth program for patients with HFrEF proved effective at improving GDMT use and reducing cardiac hospitalizations. [...]
CONCLUSIONS: The SMART formulary reduced the total cost of care for a cohort of charitable care patients enrolled in a primary care clinic at a large urban academic medical center in Baltimore, Maryland. [...]
CONCLUSION: Clinical pharmacist education improved diabetes self-care practices and metabolic outcomes, including glycemic control and lipid profiles, demonstrating its role in achieving therapeutic goals for patients with T2DM. [...]
Heart failure with reduced ejection fraction is a chronic, progressive medical condition affecting millions of individuals worldwide. It is associated with high morbidity and mortality. The use of "foundational quadruple therapy" titrated to the maximum tolerated doses improves survival, quality of life, and reduces heart failure-related hospitalisation. Despite this evidence, [...]
CONCLUSION: The P3ID trial tests the hypothesis that a jointly led pharmacist-physician intervention in an outpatient will reduce the total number of medications, improve medication adherence, reduce falls and improve patients' and doctors' satisfaction towards pharmacist services. Findings from this study would inform future deprescribing practices, particularly in LMIC, pertaining [...]
Developed nations maximize pharmacists, while developing nations underutilize them, especially in operating rooms (ORs), necessitating cost-effectiveness and feedback evaluations. We investigated the impact of pharmacist involvement in operating rooms (OR) at Muhimbili National Hospital. We contrasted a "before era" (BE) without pharmacists to an "after era" (AE) with their presence. [...]
CONCLUSIONS: Patients in the PPCC group were more likely to meet comprehensive diabetes care quality measures compared with SC. These results underscore the value of pharmacists in diabetes management in primary care and their contribution to value-based care. [...]
Medication adherence is crucial for slowing chronic kidney disease (CKD) progression. A specially designed pharmacist-led mobile application, Kidney Health, was evaluated in a single-center, prospective, 3 months, randomized controlled trial (RCT) to assess its impact on medication adherence and efficacy in patients with CKD. 86 patients were randomly assigned to [...]
Background There is good evidence describing on-call pharmacy services internationally; however, there is limited evidence evaluating out-of-hours (OOH) calls from adult critical care units. Our primary objective is to describe the characteristics of OOH calls from adult critical care units to resident pharmacists, to inform service provision to this high-risk [...]
CONCLUSION: Pharmacist support in entering blood drug concentration test orders significantly reduced vancomycin-induced kidney injury frequency and shortened time to first TDM, enhancing patient safety during anti-MRSA medication administration in the emergency and critical care center. This task-shifting approach demonstrates clear benefits for patient care and physician workload. [...]
CONCLUSIONS: Results of this study will further elucidate the role of pharmacist-led CGM in primary care. [...]
To combine didactic education with clinical and research experiences that would empower student pharmacists to consider postgraduate training and a career in pharmacy education or academics, in 2009, the Next Generation of Pharmacist Educators (NextGenRxEd) program, a four-year longitudinal education program, was implemented at the University of California San Diego [...]
Accessing essential healthcare services presents a challenge for consumers living in rural and remote communities, leading to higher rates of chronic disease and poorer health outcomes. Community pharmacists are well positioned to address this lack of access; thus, this study aimed to explore the perceptions of rural and remote consumers [...]
CONCLUSIONS: This study highlights the positive impact of pharmacist consultations on enhancing knowledge and safety skills in patients with IA and treated with bDMARDs. The lack of a control group limits interpretation of the finding. [...]
CONCLUSION: The lack of regulation has contributed to unstandardized telepharmacy practice. Despite the untapped potential, the growth of telepharmacy services in Indonesian community pharmacies is uncertain, with ongoing support from the regulation needed. [...]
IntroductionAt the University of California Irvine (UCI) in Orange County California, we published an implementation study to evaluate the use of an electronic patient-reported outcome (ePRO) tool to guide pharmacist-led chemotherapy education in newly diagnosed cancer patients. The goal of this secondary analysis was to describe the types of pharmacist-led [...]
This systematic review aimed to evaluate the association between pharmacists' interventions and health outcomes of patients with type 2 Diabetes Mellitus (DM) in the Middle East. A comprehensive database search was conducted in July 2024 using the electronic databases of PubMed, MEDLINE, Embase, Cochrane Library, Web of Science and Scopus. [...]
CONCLUSIONS: This study shows that identifying functional difficulties in medication preparation enables tailored interventions to address these issues. Observing older adults' abilities to manage their medication could reduce the risk of medication errors and probably enhance their daily quality of life. [...]
CONCLUSION: The intervention studied improved family physicians' knowledge of medication for type 2 diabetes, reduced the number of medication issues for patients, and improved their FPG concentrations. It should provide a valuable reference for chronic disease management. This pharmacist-led training approach could be expanded to improve medication practices and patient [...]
CONCLUSION: Pharmacist-led interventions led to a significant improvement in HbA1c levels. While medication expenses increased in both groups from the initial follow-up, the control group exhibited a significantly greater increase in costs and HbA1c levels than the intervention group. [...]
CONCLUSION: This study demonstrates that a hospital-based pharmacist-led post-discharge medication review clinic reduced 30-day hospital readmissions in adult patients compared to a group of case-matched controls. This study provides evidence to support extending pharmaceutical care beyond the inpatient hospital setting into the early post-discharge period, particularly in hospitals providing comprehensive [...]
CONCLUSION: Pharmacist-led MedRec services improved continuity of care for elderly patients. Implementing a structured reconciliation process successfully resolved discrepancies and reduced hospital readmissions as well as ED visits at 30-days post-discharge. This outlines potentials for healthcare cost savings. Future studies are recommended to explore long-term benefits, cost-effectiveness, and integrating pharmacist-led [...]
CONCLUSION: Our findings reveal that clinical pharmacist-provided services could positively affect outcomes in BD-I patients. [...]
CONCLUSION: While our study did not find a statistically significant difference in pharmacist-led deprescribing, there was a trend towards reduction in high-risk medication use. This suggests potential clinical significance, emphasizing the role of pharmacist involvement in prescribing practices of medications used to treat T2DM, including deprescribing high-risk medications and initiating [...]
CONCLUSION: This study underscores the considerable advantages of integrating pharmacists into diabetes management programs, particularly for patients with elevated A1c levels >9%. [...]
CONCLUSIONS: Pharmacists are well-placed to play a broader role in SEM but face systemic and educational barriers. Enhancing training, establishing formal referral and interdisciplinary communication pathways and addressing structural challenges could improve engagement. This study lays the groundwork for future interventions to enhance pharmacists' contributions to SEM and strengthen pharmacist-physiotherapist [...]
CONCLUSION: This study highlights the frequent occurrence of DRPs and LT4 therapy adherence problems in patients with HoT. The findings suggest that the intervention of CPs, by increasing adherence to LT4 therapy and decreasing DRPs, could significantly contribute to improving patients' treatment outcomes. [...]
PurposeThe time to complete oncology pharmacist tasks is needed to determine workload and productivity. The Hematology/Oncology Pharmacy Association (HOPA) and the Hematology/Oncology Practice and Research Network (PRN) of the American College of Clinical Pharmacy (ACCP) partnered with the aim of establishing consensus on the time required to complete oncology pharmacy [...]
CONCLUSION: SMPOP service enhances prescription appropriateness, reduces ADRs, shortens stays, and lowers costs, underscoring the need for continuous innovation in healthcare. [...]
CONCLUSION: CBE improved pharmacists' knowledge of POCT but showed a limited effect on pharmacist intention or behaviour. The study highlighted that knowledge alone does not influence behaviour change. Factors such as organizational support, adequate reimbursement, and expanded practice scope (e.g., prescribing) are critical to enhance POCT implementation. [...]
CONCLUSIONS: During hospitalization, there was no group difference in the primary outcome of high-intensity statin therapy. Feasibility of an effective pharmacist-initiated intervention for improvement of lipid management was demonstrated by entry of recommendations in the discharge summary and related adjustment in outpatient statin therapy. The main opportunity for future improvement [...]
Respiratory tract infections (RTIs) are prevalent in India, affecting approximately 11.3% of the population. India leads globally in lung disease mortality, including chronic obstructive pulmonary disease and asthma, contributing significantly to disability-adjusted life years and mortality rates. The role of clinical pharmacist interventions (CPIs) in optimizing antibiotic use and managing [...]
Background: During the coronavirus disease 2019 (COVID-19) pandemic, many clinical practices shifted to using virtual platforms to care for patients. After in-person visits resumed, many patients continued to participate in virtual care. Objective: This study evaluated the impact of hybrid care (virtual and in-person visits) on diabetes control in patients [...]